Search results
Results from the WOW.Com Content Network
Waning demand for COVID vaccines and anticipation of a loss for 2023 led to a steep decline in Moderna's shares last year. Moderna reports surprise profit, sets out road map for RSV vaccine Skip ...
The Moderna news followed preliminary results from the Pfizer-BioNTech vaccine candidate, BNT162b2, with Moderna demonstrating similar efficacy, but requiring storage at the temperature of a standard medical refrigerator of 2–8 °C (36–46 °F) for up to thirty days or −20 °C (−4 °F) for up to four months, whereas the Pfizer-BioNTech ...
Moderna is on its way to getting a third mRNA-based vaccine approved by the FDA if the regulatory agency likes the data released Monday for a combination flu-COVID shot.The company said the new ...
(Reuters) -Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer and BioNTech.
The updated Covid vaccines should be more accessible, experts say. Saturday 16 September 2023 21:00, Maggie O’Neill. The cost of the new Covid vaccines may prohibit some people from getting them ...
Moderna Inc (NASDAQ: MRNA) reported mixed quarterly results Thursday and suggested an interim efficacy readout from the Phase 3 study is likely in November.The Moderna Bull Case: Moderna's vaccine ...
Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday gave Pfizer permission to take the case to the Court of Appeal. Pfizer and ...
Following lab tests, Moderna said its current version of the vaccine would continue to be its "first line of defense against Omicron."